BUND FINANCE

BUND FINANCE › Stocks › WST

West Pharmaceutical Services, Inc. (WST)

NYSE · Stock price, chart and technical analysis

US$404.02-10.10 (-2.44%)

Data from Financial Modeling Prep · Nov 18, 2026, 4:01 PM New York time · may be delayed

Open the live chartSee Technicals⏱ Analyze entryQuarterly earnings📅 See in calendar💬 Explain this move⇄ ComparePractice in the Simulator

Key stats

Previous closeUS$414.12
OpenUS$412.89
Day rangeUS$402.85 – US$416.96
52-week rangeUS$223.83 – US$438.27
Market capUS$28.14B
Volume593,653
50-day averageUS$383.26
200-day averageUS$323.21
Beta1.14
Last dividend per shareUS$0.9200

Quick technical read

This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it

Fundamentals Annual

Fiscal year20212022202320242025
RevenueUS$2.8BUS$2.9BUS$3.0BUS$2.9BUS$3.1B
Net incomeUS$661.8MUS$585.9MUS$593.4MUS$492.7MUS$493.7M
EPS (diluted)8.677.737.886.696.80
Gross margin41.5%39.5%38.4%34.7%35.9%
Operating margin26.8%26.5%24.1%20.6%20.1%
Net margin23.4%20.3%20.1%17.0%16.1%
Free cash flowUS$330.6MUS$439.4MUS$414.5MUS$276.4MUS$468.9M
Total debtUS$325.3MUS$317.9MUS$309.0MUS$305.3MUS$416.7M
CashUS$762.6MUS$894.3MUS$853.9MUS$484.6MUS$791.3M

Compound annual growth: revenue 2.1% · net income -7.1% (4 years).

Valuation: today, its history and its sector

Today5-year averageSector median (Healthcare)
P/E45.3x43.1x27.1x
EV / EBITDA28.9x29.5x16.5x
Operating margin23.0%—3.6%
Net margin18.8%—-0.0%
Debt / equity0.37—0.58

Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation.

About West Pharmaceutical Services, Inc.

SectorHealthcare
IndustryMedical - Instruments & Supplies
CountryUS
CEOMichel Lagarde
Employees10,800
IPO date1980-03-17

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides …

www.westpharma.com

Other stocks on BUND FINANCE

Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice